Clinical Trials Browser

Borderline Resectable Pancreatic Cancer

Stomach Neoplasms

Stomach Neoplasms

Adenocarcinoma Of Esophagus, Esophageal Neoplasms

Carcinoma, Basal Cell

Colorectal Neoplasms

Colorectal Neoplasms

Squamous Cell Carcinoma of Head and Neck

Rectal Neoplasms, Colorectal Neoplasms

Pancreatic Neoplasms

Colorectal Neoplasms

Carcinoma, Hepatocellular

Colorectal Neoplasms

Carcinoma, Digestive System Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms

Rectal Neoplasms

Colorectal Neoplasms

Sinonasal Tumors

Unresectable Sinonasal Tumors

Hepatocellular Carcinoma Resectable

Liver, Cancer of, Primary Resectable

Colorectal Neoplasms

Keratosis, Actinic

Carcinoma, Hepatocellular

Colonic Neoplasms, Neuritis, Colorectal Neoplasms, Mucositis

Neoplasm Metastasis, Pancreatic Neoplasms

Carcinoma, Hepatocellular

Rectal Neoplasms

Esophageal Squamous Cell Carcinoma

Esophageal Squamous Cell Carcinoma

Carcinoma, Hepatocellular

Neoadjuvant Therapy

Colonic Neoplasms, Colorectal Neoplasms

Neo-adjuvant Short Course Chemo-radiotherapy in Locally Advanced Cancer Rectum

MSI-H Advanced Colorectal Cancer

Bile Duct Neoplasms, Cholangiocarcinoma

Nasopharyngeal Carcinoma

High-risk Locally Advanced Colorectal Cancer

Carcinoma, Hepatocellular

Pancreatic Adenocarcinoma

Stomach Neoplasms

Cholangiocarcinoma

Colorectal Cancer Metastatic

Locoregionally Advanced Laryngo-hypopharyngeal Squamous Cell Cancer

Solid Tumors

Colonic Neoplasms

Colorectal Neoplasms

Rectal Neoplasms

Gastrointestinal Neoplasms, Stomach Neoplasms

Stomach Neoplasms

Esophageal Squamous Cell Carcinoma, Carcinoma, Squamous Cell, Esophageal Neoplasms

Clinical Trials

NALIRIFOX in Combination With Camrelizumab for BRPC: a Prospective, Exploratory Study

IMAGINE

Gastric Cancer Organoids in the Screening of Neoadjuvant Drugs

FOLFOX-6 Induction Chemotherapy Followed by Esophagectomy and Post-operative Chemoradiotherapy in Patients With Esophageal Adenocarcinoma

The Efficacy and Safety of Using Intralesional 5-fluorouracil for Basal Cell Carcinoma

AIO-KRK-0116

REVOLUTION

Toripalimab in Combined With Cetuximab，Chemotherapy for Conversion Therapy of Locally Nonresectable OCSCC

BRAZIL-TNT

Study of Immunotherapy Combined With Chemotherapy in Locally Advanced and Metastatic Pancreatic Cancer

INTERACT-II

A Trial of Conversion Treatment of HAIC Combined With Camrelizumab and Apatinib for Unresected Hepatocellular Carcinoma

Precision Chemotherapy Based on Organoid Drug Sensitivity for Colorectal Cancer

Hepatic Artery Infusion Chemotherapy Plus Donafenib in Patients With Hepatocellular Carcinoma After Surgery

Induction Chemotherapy Followed by Short Course Radiotherapy in Rectal Cancer

HIPEC

Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Operable Patients

Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Inoperable Patients

Applicability of PDOX in Patients With Primary Liver Cancer: A Randomized Controlled Trial

Applicability of 3D-HDRA in Patients With Primary Liver Cancer: A Randomized Controlled Trial

FIND

PACKS

Combination Therapy of HAIC, Sintilimab and Bevacizumab for Advanced Hepatocellular Carcinoma

Protective Effect of Pentoxifylline Against Chemotherapy Induced Toxicities in Patients With Colorectal Cancer

FOOTPATH

HAIC Combined With Donafenib Tosilate and Toripalimab for Unresectable HCC

Bevacizumab, Fluorouracil, Leucovorin Calcium, and Oxaliplatin Before Surgery in Treating Patients With Stage II-III Rectal Cancer

Tislelizumab in Combination With Chemotherapy for Conversion Therapy of Locally Nonresectable ESCC

Study of Neoadjuvant Nivolumab or Placebo Plus Chemotherapy Followed by Surgery and Adjuvant Treatment in Subjects With Resectable ESCC

Hepatic Arterial Infusion of Raltetrexed With Oxaliplatin(SALOX) Versus FOLFOX in Advanced Hepatocellular Carcinoma

The Clinical Efficacy of Drug Sensitive Neoadjuvant Chemotherapy Based on Organoid Versus Traditional Neoadjuvant Chemotherapy in Advanced Rectal Cancer

Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery

Neo-adjuvant Short Course Chemo-radiation Therapy in Locally Advanced Rectal Cancer Patients

PD-1 Inhibitor Combined With Bevacizumab and FOLFIRI Regimen in the Second-line Treatment of Advanced Colorectal Cancer

Neoadjuvant mFOLFOXIRI for Potentially Resectable Cholangiocarcinoma

Reduced-dose Radiotherapy for Low-risk Stage III Patients With Nasopharyngeal Carcinoma

FOLFOXIRI for Neoadjuvant Treatment of High-risk Locally Advanced Colorectal Cancer

Hepatic Artery Infusion Chemotherapy for Unresectable Hepatocelluar Carcinoma Who Failed to Systemic Therapy

nITRo

Triplet Combination of Cytotoxics as First-line Treatment for Metastatic Gastric Cancer

HAIC With FOLFOX Versus Systemic Chemotherapy With GP for Unresectable ICC

BEYOND

Induction Chemotherapy Combined With Toripalimab in Locoregionally-Advanced Laryngo-Hypopharyngeal Squamous Cell Cancer

ASLAN001 in Combination With Oxaliplatin and Capecitabine or Oxaliplatin and 5-FU With Leucovorin

Neoadjuvant FOLFOXIRI Chemotherapy in Patients With Locally Advanced Colon Cancer

Neoadjuvant FOLFOXIRI Chemotherapy in Resectable Liver Metastasis of Colorectal Cancer

Totally Neoadjuvant FOLFOXIRI + Short-course Radiation + XELOX in Patients With Locally Advanced Rectal Cancer

RusGCG-01

IRIGA

PET Imaging-guided Chemoradiotherapy in Esophageal Squamous Cell Carcinoma